Supergen buys rights to Immunex ' s etoposide . SuperGen Inc said on Thursday it bought the rights to Immunex Corp ' s generic version of the anticancer drug etoposide . The terms were not disclosed . The purchase includes the rights to Immunex ' s form of the drug , cleared by the U . S . Food and Drug Administration in 1996 , as well as Immunex ' s inventory of the product . 
